This is the new date for the webinar that was postponed.

Join us for an insightful webinar on Monday, 21st October 2024, at 1:30 PM BST to discuss the findings of the Cannabinoid Research and Development Group's (CRDG) latest report, Strengthening Cannabinoid Research & Development: Controlled Drugs Licensing Reforms for UK Medical and Scientific Research in Academia and Industry.

The report, authored by Professor Trevor Jones CBE FMedSci and Zack Bellman, reveals critical delays in cannabinoid clinical trials due to outdated and complex licensing regulations by the UK Home Office. The report is now available to download on crdg.uk.

In this webinar, key experts, including Dr. Andy Yates, Chief Scientific Officer at Artelo Biosciences and Rob Bennett, General Counsel at Oxford Cannabinoid Technologies, will delve into the challenges facing cannabinoid research in the UK and explore how regulatory reforms could unlock opportunities for groundbreaking medical treatments.

Panel:
Dr Andy Yates, Chief Scientific Officer at Artelo Biosciences
Rob Bennett, General Counsel at Oxford Cannabinoid Technologies
Zack Bellman, Researcher at CRDG

Host: Dr Elisabeth Philipps, Advisory Board member at CRDG

Strengthening Cannabinoid R&D: Controlled Drugs Licensing Reforms for UK Medical Research